Aller au contenu principal
Accès ouvert déclaré 2026 article

Poster Session II - A257 THE ROLE OF BACTERIAL LPC AND LPA IN CHRONIC ABDOMINAL PAIN: A LONGITUDINAL STUDY IN PATIENTS WITH IBD

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : fr. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Background Patients with inflammatory bowel disease (IBD) often experience abdominal pain, despite being in remission, and many associate their pain with the intake of certain foods. Emerging evidence links lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) to neuropathic pain, with preclinical studies suggesting that gut bacteria are able to produce these compounds from dietary phosphatidylcholine (PC). Aims To study the association between fecal LPC and LPA, abdominal pain, and dietary PC intake in patients with IBD. Methods IBD patients in remission (determined endoscopically and/or by fecal calprotectin<250 mg/kg) with chronic abdominal pain were enrolled in a longitudinal study. Pain was assessed by the Visual Analog Scale (VAS), and stool samples were collected daily for at least one week; diet was studied by a 3-day diary. Fecal LPC and LPA were extracted using Bligh-Dyer and solid phase extraction techniques and analysed using Liquid Chromatography-Mass Spectrometry (LC-MS). Dietary intake, focused on total choline and PC, was assessed by ESHA software. Results Eight patients (female=6; Crohn’s disease=2, UC = 6; age 43.5 [endif]-->5.3 years) completed the study. Patients with previous bowel surgery reported higher pain scores compared to those without surgery (49.8 [endif]-->8.9 vs 19.7 [endif]-->9.2). Fecal LPA and LPC were elevated in periods of high pain compared to low pain (Table 1). The estimated choline intake was 358.8 [endif]-->48.4 and 297.8 [endif]-->29.3 mg/d in males and females, respectively (adequate intake 550 and 425 mg/d). The estimated PC intake was 233.0 [endif]-->43.8 and 160.1 [endif]-->24.3 mg/d in males and females, respectively. There was no clear association between intake of PC and pain scores. Conclusions IBD patients with colitis in remission suffer from chronic abdominal pain, more severe in those with previous bowel resection. Fecal LPC and LPA concentrations fluctuate, with higher levels associated with high pain. Patients with IBD have low choline intake, possibly unconsciously avoiding dietary substrates for bacterial LPC and LPA production. Funding Agencies Crohn’s Colitis Foundation (US), J.A received Ph.D scholarship from Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Poster Session II - A257 THE ROLE OF BACTERIAL LPC AND LPA IN CHRONIC ABDOMINAL PAIN: A LONGITUDINAL STUDY IN PATIENTS WITH IBD
Date Crossref
01/02/2026
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Gastrointestinal motility and disordersInflammatory Bowel DiseasePancreatitis Pathology and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.